Trial Profile
A Randomised Open-label Multi-centre Comparative Study to Evaluate Cycle Control of 2 Dosages of Estetrol Combined With Either P1 or P2, Compared to a Combined Oral Contraceptive Containing E2V and DNG.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Estetrol (Primary) ; Estradiol valerate/dienogest
- Indications Pregnancy
- Focus Therapeutic Use
- Acronyms FIESTA study
- Sponsors Estetra SPRL
- 27 Feb 2012 Actual patient number (396) added as reported by ClinicalTrials.gov.
- 23 Sep 2011 Actual end date (September 2011) added as reported by ClinicalTrials.gov.
- 23 Sep 2011 Status changed from active, no longer recruiting to completed according to ClinicalTrials.gov.